OncLive | Bringing the Global Oncology Community Together

The guidelines for establishing HER2 status for patients with breast cancer with unclear results on initial testing have been finetuned in an update that the American Society of Clinical Oncology and the College of American... Read More >>

Patient-Experienced Toxicity Is a Biomarker Worth Considering

FDA Approves Nivolumab for Small Cell Lung Cancer

FDA Approves Lenvatinib for Frontline HCC

SL-401 Emerging as First Targeted Therapy for Rare Blood Cancer

Updates Continue in Oncogene-Driven Lung Cancer

View More Stories >>

View Conference Coverage

2018 International Lung Cancer Congress

2018 Pan Pacific Lymphoma Conference

2nd Annual Live Medical Crossfire® : Hematologic Malignancies

State of the Science Summit on A Summer of Progress: Updates from ASCO 2018

2018 State of the Science Summit on Breast Cancer

Dr. Borghaei on the FDA Approval of Nivolumab in Small Cell Lung Cancer

Dr. Matulonis Discusses QoL Data from GOG-258 in Endometrial Cancer

Dr. Holstein Discusses Triplets and Quadruplets in Myeloma

Dr. Bekaii-Saab Discusses the FDA Approval of Lenvatinib in HCC

Dr. Roschewski on the Treatment of Burkitt Lymphoma in Adults

OncLive houses thousands of videos that provide updates and information.
See more Videos

Case Study: Recurrent Synovial Sarcoma

Considerations for Using Adjuvant Therapy in mRCC

Polycythemia Vera: Novel JAK Inhibitors

Emerging Treatment Regimens in Advanced NSCLC

Recent Clinical Trial Data in Locally Advanced CRC

Neoadjuvant Therapy in Advanced Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

Nondriver mNSCLC: Incorporating Trial Data into Practice

VEGF and PD-1 Inhibition in Advanced Gastric/GEJ Cancer

Bevacizumab and Interferon in mRCC

HR+ Breast Cancer: Prognostic Subgroups in MONARCH Trials

Next-Generation Sequencing in HR+ Metastatic Breast Cancer

Non-Small Cell Lung Cancer: Other Actionable Mutations

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured

A First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Featured

Dr. Wirth on the Use of Lenvatinib in Hypertensive Patients With Thyroid Cancer

Lori J. Wirth, MD, of Massachusetts General Hospital, discusses the use of lenvatinib (Lenvima) in hypertensive patients with thyroid cancer.

View more >>>

Featured Video

Immunotherapy in the Treatment of Follicular Lymphoma

Ian W. Flinn, MD, PhD; Grzegorz S. Nowakowski, MD; Loretta J. Nastoupil, MD; and Anas Younes, MD, reflect on the value of immunotherapy, immunotherapy combination strategies, and understanding the tumor microenvironment in treating follicular lymphoma.View now

FDA Approval in CTCL, Breakthrough Therapy Designation in CRC, and More